This site uses cookies to provide you with a more responsive and personalised service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print page

Access to cancer medicines in Australia

Access to cancer medicines in AustraliaCancer is an area of high clinical need in Australia.

Past investment in cancer care has resulted in the country being a world leader in cancer control, but disease incidence is projected to grow significantly over the next 20 years.

In this report for the Medicines Australia Oncology Industry Taskforce, Deloitte Access Economics has assessed the disease patterns and economics of cancer in Australia and internationally, and canvassed the opinions of various stakeholders on issues pertaining to patient access to cancer medicines.

Related links


Follow us


Talk to us